Back to search

A Pilot study of allogeneic cellular therapy for patients with advanced hematologic malignancies

Data up to Jan 2025

Published2008
Citations14
References50

Total Citations Per Year

Abstract

References (50)

Cancer immunoediting: from immunosurveillance to tumor escape

2002 • 4,911 citations

The Immunobiology of Cancer Immunosurveillance and Immunoediting

2004 • 2,788 citations

Regulatory T cells, tumour immunity and immunotherapy

2006 • 2,009 citations

Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma

2005 • 1,613 citations

Progress in human tumour immunology and immunotherapy

2001 • 1,327 citations

Cancer despite immunosurveillance: immunoselection and immunosubversion

2006 • 1,263 citations

Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia

2000 • 679 citations

Tumor-Specific Human CD4+ Regulatory T Cells and Their Ligands

2004 • 525 citations

Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes

2004 • 368 citations

Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies

2007 • 337 citations

Increased intensity lymphodepletion and adoptive immunotherapy—how far can we go?

2006 • 333 citations

Tolerance and Cancer: Mechanisms of Tumor Evasion and Strategies for Breaking Tolerance

2004 • 319 citations

Regulatory T cells in immune surveillance and treatment of cancer

2006 • 257 citations

Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation

2003 • 219 citations

Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells

2003 • 219 citations

A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity

2001 • 212 citations

Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self

2006 • 163 citations

Minor histocompatibility antigens in human stem cell transplantation

2003 • 137 citations

Graft-Versus-Tumor Induction With Donor Leukocyte Infusions as Primary Therapy for Patients With Malignancies

1999 • 131 citations

Anti-tumor immunity and autoimmunity: a balancing act of regulatory T cells

2003 • 110 citations

Antitumor effect of donor marrow graft rejection induced by recipient leukocyte infusions in mixed chimeras prepared with nonmyeloablative conditioning: critical role for recipient-derived IFN-γ

2003 • 83 citations

Anti‐tumour response despite loss of donor chimaerism in patients treated with non‐myeloablative conditioning and allogeneic stem cell transplantation

2005 • 82 citations

The graft versus leukemia response after allogeneic hematopoietic stem cell transplantation

2003 • 79 citations

Effector-phase tolerance: another mechanism of how cancer escapes antitumor immune response

2006 • 73 citations

Innate Immune Recognition and Suppression of Tumors

2006 • 70 citations

Minor Histocompatibility Antigens

2004 • 70 citations

New Developments in Allotransplant Immunology

2003 • 67 citations

Natural-killer-cell-based treatment in haematopoietic stem-cell transplantation

2006 • 66 citations

Use of B cell-bound HLA-A2 class I monomers to generate high-avidity, allo-restricted CTLs against the leukemia-associated protein Wilms tumor antigen

2004 • 62 citations

Current status of haploidentical stem cell transplantation

2006 • 57 citations

Tumour immunology, vaccination and escape strategies

2003 • 54 citations

Vaccination for Leukemia

2006 • 52 citations

Haploidentical Stem Cell Transplantation: The Always Present but Overlooked Donor

2005 • 52 citations

Donor Lymphocyte Infusion: The Use of Alloreactive and Tumor-Reactive Lymphocytes for Immunotherapy of Malignant and Nonmalignant Diseases in Conjunction with Allogeneic Stem Cell Transplantation

2002 • 52 citations

Low-dose total body irradiation followed by allogeneic lymphocyte infusion may induce remission in patients with refractory hematologic malignancy

2002 • 49 citations

High PR3 or ELA2 expression by CD34+ cells in advanced-phase chronic myeloid leukemia is associated with improved outcome following allogeneic stem cell transplantation and may improve PR1 peptide–driven graft-versus-leukemia effects

2007 • 41 citations

Transfer of PR1-specific T-cell clones from donor to recipient by stem cell transplantation and association with GvL activity

2007 • 41 citations

Part II: Vaccines for haematological malignant disorders

2004 • 36 citations

Adoptive T cell therapy of solid cancers

2005 • 33 citations

Tumor microenvironments, the immune system and cancer survival.

2005 • 28 citations

Antineoplastic Effects of Partially HLA-Matched Irradiated Blood Mononuclear Cells in Patients With Renal Cell Carcinoma

2003 • 27 citations

Minor histocompatibility antigens as targets of cellular immunotherapy in leukaemia

2004 • 26 citations

Clonal dominance of chronic myelogenous leukemia is associated with diminished sensitivity to the antiproliferative effects of neutrophil elastase

2003 • 25 citations

Expansion of CD8+ Cytotoxic T Cells in vitro and in vivo Using MHC Class I Tetramers

2007 • 21 citations

Induction of viral and tumour specific CTL responses using antibody targeted HLA class I peptide complexes

2002 • 17 citations

Nonmyeloablative Blood Stem Cell Transplantation as Adoptive Allogeneic Immunotherapy for Metastatic Renal Cell Carcinoma

2001 • 16 citations

Graft-versus-Host Disease, the Graft-versus-Leukemia Effect, and Mixed Chimerism following Nonmyeloablative Stem Cell Transplantation

2003 • 15 citations

Low Dose Total Body Irradiation Followed by Allogeneic Lymphocyte Infusion for Refractory Hematologic Malignancy—an Updated Review

2004 • 14 citations

Cellular immune therapy for refractory cancers: novel therapeutic strategies

2005 • 12 citations

The basis of T-cell-mediated immunity to chronic myelogenous leukemia

2002 • 11 citations

Cited By (0)

Loading...
A Pilot study of allogeneic cellular therapy for patients with advanced hematologic… (2008) – Leukemia Research | Metascience Observatory Explorer